BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7912517)

  • 1. Clinical development of Taxol.
    Arbuck SG; Christian MC; Fisherman JS; Cazenave LA; Sarosy G; Suffness M; Adams J; Canetta R; Cole KE; Friedman MA
    J Natl Cancer Inst Monogr; 1993; (15):11-24. PubMed ID: 7912517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes].
    Chazard M; Pellae-Cosset B; Garet F; Soares JA; Lucidi B; Lavail Y; Lenaz L
    Bull Cancer; 1994 Mar; 81(3):173-81. PubMed ID: 7894125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nursing management of the patient receiving Taxol therapy.
    Noone MH; McCabe MS; Denicoff AM; Lepore JM
    J Natl Cancer Inst Monogr; 1993; (15):149-54. PubMed ID: 7912521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current dosage and schedule issues in the development of paclitaxel (Taxol).
    Arbuck SG; Canetta R; Onetto N; Christian MC
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):31-9. PubMed ID: 8102016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Taxol--a new cytostatic drug for therapy of ovarian and breast cancer].
    Meden H; Rath W; Kuhn W
    Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):187-93. PubMed ID: 7912212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paclitaxel (Taxol)].
    Hájek R
    Cas Lek Cesk; 1996 Jun; 135(12):393-6. PubMed ID: 8706079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of paclitaxel (Taxol).
    Rowinsky EK; Donehower RC
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):16-25. PubMed ID: 8102014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel: current developmental approaches of the National Cancer Institute.
    Arbuck SG
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological action of paclitaxel].
    Potemski P; Płuzańska A
    Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol plus radiation for head and neck cancer.
    Rosenthal DI; Carbone DP
    J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.
    Forastiere AA
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):56-60. PubMed ID: 8102018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
    Hudis CA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
    ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxol: a case study.
    DeLaPena LB; Pyron S; Nichols J
    Cancer Nurs; 1993 Dec; 16(6):423-30. PubMed ID: 7906612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.